Mechanistic analysis of pancreatic ductal carcinogenesis in Hamsters

Pancreas

Volumn 16, Issue 3, 1998, Pages 300-306

  Konishi, Yoichi ^a   Tsutsumi, Masahiro ^a   Tsujiuchi, Toshifumi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; Carcinogenesis; Pancreatic duct

Indexed keywords

PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; MALE; NONHUMAN; ONCOGENE K RAS; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYRIAN HAMSTER; TUMOR SUPPRESSOR GENE;

EID: 0031944562     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199804000-00015     Document Type: Review

References (38)

1. Longnecker DS. Adenocarcinoma of the pancreas in azaserinetreated rats. Cancer Res 1975:35:2249-58.
2. Konishi Y, Denda A, Inui S, Takahashi S, Kondo H, Pancreatic carcinoma induced by 4-hydroxyaminoquinolone 1-oxide after partial pancreatectomy and splenectomy in rats. Gann 1976;67: 919-20.
3. Pour P, Kruger FW, Althoff J, Cordesa A, Mohr U. Effect of beta-oxidized nitrosamines on Syrian golden hamsters. M.2-2'Dihydroxy-di-A'-propylnitrosamine. J NatI Cancer /nst 1975;54: 141-6.
4. Pour PM, Wilson RB, Experimental tumors of the pancreas. In: Moosa AR, ed. Tumors of the pancreas. Baltimore: Williams & Wilkins, 1980;37-158.
5. Scarpelli DG, Rao MS, Subbarao V. Augmentation of carcinogenesis by Ar-nitrosobis (2-oxopropyl) amine administered during S phase of the cell cycle in regenerating hamster pancreas. Cancer Res 1983:43:611-6.
6. Kruger FW, Pour P, Althoff J. Induction of pancreatic tumors by diisopropylnitrosamine. Natunvissenschaften 1974;61:328.
7. Pour PM, Salmasi SZ, Runge RG. Selective induction of pancreatic ductular tumors by single dose of A'-nitrosobis (2-oxopropyl) amine in Syrian golden hamsters. Cancer Lett 1978:4:317-23.
8. Solt D, Farber E. New principle for the analysis of chemical carcinogenesis. Nature 1976;263:701-3.
9. Pilot HC, Barsness L, Goldworthy T. Biochemical characterization of stages of hepatocarcinogenesis after a single dose diethylnitrosamine. Nature 1978;271:456-8. 10. Mizumoto K, Tsutsumi M, Denda A, Konishi Y. Rapid production of pancreatic carcinoma by initiation with W-nitrosobis (2-oxopropyl) amine and repeated augmentation pressure in hamsters. J Natl Cancer Inst 1988;80:1564-7.
10. Mizumoto K, Tsutsumi M, Kitazawa S, Denda A, Konishi Y. Usefulness of rapid production model for pancreatic carcinoma in male hamsters. Cancer Lett 1990;49:211-5.
11. Mizumoto K, Kitazawa S, Ito S, et al. Cycles of repeated augmentation pressure in rapid production of pancreatic and cholangiocellular carcinomas in hamsters initiated with W-nitrosobis (2-oxopropyl) amine. Carcinogenesis 1989;10:1457-9.
12. Mori T, Tsutsumi M, Noguchi O, et al. Characterization of three cloned cell lines from TV-nitrosobis (2-hydroxopropyl) amine induced transplantable hamster pancreatic ductal adenocarcinoma. hl J Pancreatol 1994;16:171-7.
13. Konishi Y, Mizumoto K, Kitazawa S, Tsujiuchi T, Tsutsumi M, Kamano T. Early ductal lesions of pancreatic carcinogenesis in animals and humans. Int J Pancreatol 1990;7:83-9.
14. Ura H, Makino T, Ito S, et al. Combined effects of cholecystectomy and lithocholic acid on pancreatic carcinogenesis of A'-nitrosobis (2-hydroxopropyl) amine in Syrian golden hamsters. Cancer Res 1986;46:4782-6.
15. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
16. Cerny W, Mangold KA, Scurpelli D. K-ras mutation is an early event in pancreatic duct carcinogenesis in Syrian golden hamster. Cancer Res 1992;52:4507-13.
17. Tsutsumi M, Kondoh S, Noguchi O, et al. K-ras gene mutation in early ductal lesions induced in a rapid production model for pancreatic carcinomas in Syrian hamsters. Jpn J Cancer Res 1993;84: 1101-5.
18. Tsutsumi M, Murakami Y, Kondoh S, et al. Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by Ar-nitrosobis (2-hydroxopropyl) amine. Jpn J Cancer Res 1993;84:956-60.
19. Ushijima T, Tsutsumi M, Sakai R, et al. Ki-ras activation in pancreatic carcinomas of Syrian hamsters induced by Af-nitrosobis (2hydroxopropyl) amine. Jpn J Cancer Res 1991;82:965-8.
20. Casey G, Yamanaka Y, Friess H, et al. p53 Mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett 1993:69:151-60.
21. Ruggeri B, Zhang SY, Caamano J, et al. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor suppressor gene. Oncogene 1992;7:1503-11.
22. Barton CM, Staddon SL, Hughes CM, et al. Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer. BrJ Cancer 1991:64:1076-82.
23. Pellegata NS, Sessa F, Renault B, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994;54:1556-60.
24. Nakamori S, Yashima K, Murakami Y, et al. Association of p53 gene mutations with short survival in pancreatic adenocarcinoma Jpn J Cancer Res 1995;86:174-81.
25. Chang KW, Mangold KA, Hubchak S, Laconi S, Scarpelli DG. Genomic p53 mutation in a chemically induced hamster pancreatic duct adenocarcinoma. Cancer Res 1994;54:3878-83.
26. Okita S, Tsutsumi M, Onji M, Konishi Y. p53 Mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters. Mol Carcinog 1995:13:266-71.
27. Egawa S, Tsutsumi M, Konishi Y, et al. The role of carcinogenesis in the tumor growth of Syrian golden hamster pancreatic cancer cell line HAD-NR. Gaslroenlerology 1995;108:1526-33.
28. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994:266:2011-5.
29. Kobitsu K, Tsutsumi M, Tsujiuchi T, et al. Shortened telomere length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines. Mol Carcinog 1997:18:153-9.
30. Yanagizawa A, Kato Y, Ohtake K, et al. C-ki-raj point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas. Jpn J Cancer Res 1991:82:1057-60.
31. Bednarek A, Budunova I, Slaga TJ, Aldaz CM. Increased telomerase activity in mouse skin premalignant progression. Cancer Res 1995:55:4566-9.
32. Tsujiuchi T, Tsutsumi M, Kido A, et al. Increased telomerase activity in hyperplastic nodules and hepatocellular carcinomas induced by a choline-deficient L-amino acid-defined diet in rats. Jpn J Cancer Res 1996:87:1111-5.
33. Blasco MA, Rizen M, Greider CW, Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multistage tumorigenesis. Nat Genet 1996; 12:200-4.
34. Imanishi K, Yamaguchi K, Suzuki M, Honda S, Yanaihara N, Abe K. Production of transforming growth factor-a in human tumor cell lines. Br J Cancer 1989:59:761-5.
35. Korc M. Growth factors and pancreatic cancer. Int J Pancreatol 1991:9:87-91.
36. Tsutsumi M, Noguchi O, Okita S, et al. Inhibitory effects of sulfation inhibitors on initiation of pancreatic ductal carcinogenesis by JV-nitrosobis (2-oxopropyl) amine in hamsters. Carcinogenesis 1995:16:457-9.
37. Amanuma T, Mizumoto K, Tsutsumi M, et al. Initiating activity of diethylnitrosamine in a rapid production model for pancreatic carcinomas in Syrian hamsters. Jpn J Cancer Res 1991;82:632-7.
38. Maruyama H, Amanuma T, Nakae D, et al. Effects of catechol and its analogs on pancreatic carcinogenesis initiated by W-nitrosobis (2-oxopropyl) amine in Syrian hamsters. Carcinogenesis 1991; 12: 1331-4.